as on
| Source : NSE
as on August 18, 2025 at 4:01 PM IST
Day's Low
Day's High
1.91%
Downside
0.26%
Upside
52 Week's Low
52 Week's High
28.66%
Downside
22.74%
Upside
Market Stats | |
Previous Close | ₹2,135.20 |
Open | ₹2,150.90 |
Volume | 71.75K |
Upper Circuit | ₹2,562.20 |
Lower Circuit | ₹1,708.20 |
Day's Low | ₹2,110.7 |
Day's High | ₹2,157.3 |
52 Week Low | ₹1,535 |
52 Week High | ₹2,641 |
Returns % | |
1 Month Return | + 1.52 % |
3 Month Return | -1.2 % |
1 Year Return | + 15.67 % |
3 Year Return | + 168.14 % |
5 Year Return | + 292.97 % |
Check Caplin Point Laboratories Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹16,230.02 Cr
Return on Equity (ROE)
22.43
PE Ratio (TTM)
28.72
Return on capital employed (ROCE)
28.84
Industry PE ratio
43.28
Beta (LTM)
1.47
P/B Ratio
7.2
Dividend Yield
0.38
PEG Ratio
2.51
Quarterly Earnings Growth YOY
20.69
EPS (TTM)
60.75
Sector
Pharmaceuticals
Book Value
276.38
Technical Analysis
Bullish
View Technical Analysis
Track how Caplin Point Laboratories Ltd P/E has moved over time to understand its valuation trends.
Caplin Point Laboratories Ltd in the last 5 years
Lowest (6.76x)
March 24, 2020
Today (28.72x)
August 14, 2025
Industry (43.28x)
August 14, 2025
Highest (40.01x)
December 27, 2024
Today’s Price to Earnings Ratio: 28.72x
Get updated buy, sell, and hold recommendations by analysts on Caplin Point Laboratories Ltd.
based on 2 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
100% of analysts recommend a 'BUY' rating for Caplin Point Laboratories Ltd. Average target price of ₹2508
Source: S&P Global Market Intelligence
Get share price movements and forecasts by analysts on Caplin Point Laboratories Ltd.
Caplin Point Laboratories Ltd price forecast by 2 analysts
Upside of17.46%
High
₹2516
Target
₹2508.00
Low
₹2500
Caplin Point Laboratories Ltd target price ₹2508, a slight upside of 17.46% compared to current price of ₹2151.7. According to 2 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Caplin Point Laboratories Ltd revenue growth forecast
Expected growth rate Q1, FY2027:56.60%
Forecast
Actual
Including amortisation and stock based compensations
Caplin Point Laboratories Ltd EPS growth forecast
EPS estimate Q1, FY2027:66.33%
Forecast
Actual
Source: S&P Global Market Intelligence
Get the annual and quarterly financial summary of Caplin Point Laboratories Ltd, including revenue, profit, loss and more.
View detailed summary of the earnings and dividend history of Caplin Point Laboratories Ltd.
Caplin Point Laboratories Ltd’s net profit jumped 23.26% since last year same period to ₹152.80Cr in the Q1 2025-2026. On a quarterly growth basis, Caplin Point Laboratories Ltd has generated 7.18% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Caplin Point Laboratories Ltd has declared dividend of ₹3.00 per share on 15 May 2025 - translating a dividend yield of 0.37%.
Read More about DividendsCheck stock indices that include Caplin Point Laboratories Ltd.
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Caplin Point Laboratories Ltd.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 70.56% | 0.00 | |
Foreign Institutions | 6.14% | 7.63 | |
Mutual Funds | 1.93% | 10.82 | |
Retail Investors | 21.05% | ||
Others | 0.32% | 9.47 |
Compare market cap, revenue, PE, and other key metrics of Caplin Point Laboratories Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
BUY | 16,230.02 | 58.59% | 0.51 | 461 | 1,694 | |
BUY | 34,960.90 | 35.99% | 0.52 | 300 | 1,051 | |
BUY | 16,822.08 | 9.72% | 0.71 | 836 | 7,234 | |
NA | 4,551.09 | -4.22% | 1.88 | -343 | 71 | |
BUY | 15,765.90 | 48.97% | 0.67 | 244 | 1,515 |
Latest news and events in one place to help you make informed investing decisions in Caplin Point Laboratories Ltd.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
In the last 3 years, CAPLIPOINT has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
FII Holding Up
Foreign Institutions have increased holdings from 5.70% to 6.14% in Jun 2025 quarter
Revenue Rich
Revenue is up for the last 20 quarters, 269.88 Cr → 533.39 Cr (in ₹), with an average increase of 3.5% per quarter
Profit Spike
Netprofit is up for the last 15 quarters, 74.95 Cr → 152.8 Cr (in ₹), with an average increase of 4.9% per quarter
MF Holding Up
Mutual Funds have increased holdings from 1.74% to 1.93% in Jun 2025 quarter
Price Rise
In the last 7 days, CAPLIPOINT stock has moved up by 1.3%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 70.56% of holdings in Jun 2025 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 31.3% return, outperforming this stock by 15.7%
Retail Holding Down
Retail Investor have decreased holdings from 21.70% to 21.05% in Jun 2025 quarter
Organisation | Caplin Point Laboratories Ltd |
Headquarters | Chennai |
Industry | Pharmaceuticals |
CEO | C C Paarthipan |
E-voting on shares | Click here to vote |
Check out the Mutual Funds with significant holdings in Caplin Point Laboratories Ltd.
Caplin Point Laboratories Ltd share price today stands at ₹2151.7, Open: ₹2150.9, Previous Close: ₹2135.2, High: ₹2157.3, Low: ₹2110.7, 52 Week High: ₹2641, 52 Week Low: ₹1535 as on .
To buy Caplin Point Laboratories Ltd shares, you need to follow these steps:
Today's traded volume of Caplin Point Laboratories Ltd is 71.75K. Which means that 71.75K shares of Caplin Point Laboratories Ltd were bought and sold on the stock market during today's trading session.
Today's market capitalisation of Caplin Point Laboratories Ltd is ₹16,230.02 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
Caplin Point Laboratories Ltd’s 52 week high is ₹2641 and 52 week low is ₹1535. The current share price of Caplin Point Laboratories Ltd is ₹2151.7, which is -18.53% down from its 52 week high and 40.18% up from its 52 week low.